Skip to main content

Articles

Page 1 of 13

  1. Hypertension is a serious threat to public health globally owing to its high prevalence and related complications. It is the main risk factor for cardiovascular disease, kidney disease, eye problems, and death...

    Authors: Dagmawi Teshome Tebelu, Tesfaye Assefa Tadesse, Mihiret Shawel Getahun, Yohannes Mekuria Negussie and Abenet Menene Gurara
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:20
  2. This paper reviews the regulations of over-the-counter (OTC) medicines in 30 European countries with the goal of identifying the regulatory trends and clusters as of May 2022.

    Authors: Eduardo Daniel López Vila, Caroline Buts and Marc Jegers
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:19
  3. Essential medicines (EMs) are those that satisfy the basic healthcare needs of the population. However, access to EMs remains a global health challenge. The World Health Organization (WHO) and the East African...

    Authors: Ayo-Oley Baldeh, Colin Millard, Allyson M. Pollock and Petra Brhlikova
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:18
  4. Pharmacists play a crucial role in the COVID-19 pandemic scenario, performing frontline roles for the community, and supporting the healthcare system. This study aimed at investigating stress and its correlate...

    Authors: Loreta Tobia, Mario Muselli, Fabio De Luca, Vincenza Cofini, Giada Mastrangeli, Leila Fabiani and Stefano Necozione
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:17
  5. Lung cancer is the leading cause of cancer deaths worldwide in both men and women, and non-small cell lung cancer (NSCLC) accounts for the majority (~ 85%) of lung cancers. This post-marketing surveillance (PM...

    Authors: Sharareh Seifi, Babak Salimi, Zahra Esfahani Monfared, Cyrus Sabahi, Hamidreza Kafi and Adnan Khosravi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:16
  6. Marketing by pharmaceutical companies has become an increasingly controversial issue for the medical community and the public. This controversy stems from the potential influence that pharmaceutical companies ...

    Authors: Amit Koplovitz, Tamar Freud and Roni Peleg
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:15
  7. Evidence-based services to support cancer patients with pain via clinical pharmacy services are currently lacking. Therefore, there is a need to undertake a randomized controlled trial (RCT) to explore the eff...

    Authors: Sunil Shrestha, Ali Qais Blebil, Siew Li Teoh, Simit Sapkota, Bhuvan KC, Vibhu Paudyal and Siew Hua Gan
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:14
  8. Mental health is a global health priority, and pharmacists have a valuable role in improving outcomes in all sectors of practice. This study sought to explore pharmacy students’ views on teaching and learning ...

    Authors: H. C. Gorton, J. Strawbridge and H. Macfarlane
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:13
  9. Mislabeling of drug allergic histories causes avoidable negative impacts on patients and healthcare system. Although multidisciplinary adverse drug reaction (ADR) services to verify and de-label drug allergic ...

    Authors: Sirinoot Palapinyo, Jettanong Klaewsongkram, Pungjai Mongkolpathumrat, Nattawut Leelakanok and Kitiyot Yotsombut
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:12
  10. Irrational prescription of antibiotics is an ongoing global public health concern, leading to antibiotic resistance. Understanding the prescribing pattern of antibiotics is important to tackling mal-prescripti...

    Authors: Gholamali Karimi, Kourosh Kabir, Babak Farrokhi, Effat Abbaszadeh, Elham Davtalab Esmaeili, Farzad Khodamoradi, Ehsan Sarbazi and Hosein Azizi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:11
  11. Since 2015, the National Health Service (NHS) has funded pharmacists to work in general practice (GP practice) to ease workload pressures. This requires pharmacists to work in new roles and be integrated effec...

    Authors: Abdullah A. Alshehri, Ali M. K. Hindi, Ejaz Cheema, M. Sayeed Haque, Zahraa Jalal and Asma Yahyouche
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:10
  12. Administering cancer drugs is a high-risk process, and mistakes can have fatal consequences. Failure Mode, Effect and Criticality Analysis (FMECA) is a widely recognized method for identifying and preventing p...

    Authors: Alessandra Buja, Giuseppe De Luca, Ketti Ottolitri, Elena Marchi, Francesco Paolo De Siena, Giovanni Leone, Pietro Maculan, Umberto Bolzonella, Riccardo Caberlotto, Giovanni Cappella, Giulia Grotto, Gaia Lattavo, Benedetta Sforzi, Giovanni Venturato, Anna Maria Saieva and Vincenzo Baldo
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:9
  13. Despite the evidence that cold chain management practices affect the potency and effectiveness of both vaccines and non-vaccine commodities, most of the researches in Uganda focus on vaccines. This study asses...

    Authors: Yona Tumwine, Kalidi Rajab, Paul Kutyabami, Jean Baptiste Nyandwi and Domina Asingizwe
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:8
  14. The uniqueness of the physician–patient relationship and the latter's lack of medical experience and knowledge necessitate providing patients with accurate and timely information necessary to engage them in tr...

    Authors: Emad Dahiyat, Faris El-Dahiyat, Ghaleb El Refae and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:7
  15. Health supply chain is crucial for proper functioning of a health system and advancing national and international health security goals. The Coronavirus 2019 pandemic caused major challenges for health supply ...

    Authors: John Hans Wasswa, Henry Oundo, Martin Olowo Oteba, Henry Komakech, Irene Ochola, Sheila Mwebaze, Denis Okidi, Anthony Kirunda, Shamim Nakadde, Neville Okuna Oteba and Eric Lugada
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:6
  16. We previously reported that a standardized pharmacist check of medical orders related to the administration criteria of anticancer drugs prior to preparation of injectable anticancer drugs was useful for reduc...

    Authors: Hirotsugu Yamada, Yuto Yamada, Hirotoshi Iihara, Ryo Kobayashi, Hiroyuki Tanaka and Akio Suzuki
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:5
  17. Different drugs have different effects on the prognosis of patients with COVID-19. This study aimed to evaluate the effect of different drug regimens on patients with COVID-19, hospitalized in Sanandaj city.

    Authors: Jalal Asadi, Mohammad Aziz Rasouli, Ebrahim Ghaderi, Daem Roshani, Behzad Mohsenpour, Yousef Moradi and Ghobad Moradi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:4
  18. Medical devices provide a great number of medical treatments and have an important role in patients’ healthcare; however, there are certain risks, sometimes even serious incidents, associated with their usage....

    Authors: Antonela Simunovic, Krunoslav Kranjcec, Marija Pekas and Siniša Tomic
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:3
  19. Older adults are among the most vulnerable groups during the COVID-19 epidemic, contributing to a large proportion of COVID-19-related death. Medication review and reconciliation by pharmacist can help reduce ...

    Authors: Chee-Tao Chang, Siti Mallissa Mohd Shariff, Nur Suriana Abu Bakar, Nasiha Sufina Ramzuzzaman, Chun Kiat Lim, Eddy Yew Joe Lim, Peng Seng Ong, Jie Min Lee, Aie Yen Tan, Siti Fatimah Kamis, Wei Mun Liew, Yuet Man Low, Doris George, James Yau Hon Voo, Hoo Seng Tan, Philip Rajan…
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:2
  20. Pharmacy in Lebanon has been taught for years, and the profession has known the golden ages in previous years. However, with the recent graduation of hundreds of pharmacists, without prior workforce planning, ...

    Authors: Aline Hajj, Rony M. Zeenny, Hala Sacre, Marwan Akel, Chadia Haddad and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:1
  21. Medication waste is a public health problem affecting developed and developing countries. In Lebanon, a developing country in the Middle East, efforts are being deployed in hospitals but not in the community.

    Authors: Aline Hajj, Souraya Domiati, Chadia Haddad, Hala Sacre, Maria Akl, Marwan Akel, Samah Tawil, Soula Abramian, Rony M. Zeenny, Fadi Hodeib and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:107
  22. In low- and middle-income countries, too, public–private partnerships in health insurance schemes are crucial for improving access to health services. Problems in the public supply chain of medicines often lea...

    Authors: Angel Dillip, Albino Kalolo, Iddy Mayumana, Melina Rutishauser, Vendelin T. Simon and Brigit Obrist
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:106
  23. Breast cancer (BC) is the most common cancer globally among women, with 2,261,419 new cases in 2020; systemic treatment may be neo-adjuvant, adjuvant, or both. BC subtype guides the standard systemic therapy a...

    Authors: Ghader Mohammadnezhad, Melika Sattarpour and Najmeh Moradi
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:105
  24. The Drug Regulatory Authority of Pakistan (DRAP) in response to the public outcry on increasing medicines prices in the country issued notifications to direct healthcare professionals to prescribe medicines wi...

    Authors: Hamid A. Merchant, Zaheer-Ud-Din Babar and Izhar M. Hussain
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:104
  25. Patient medication counselling (PMC) is a pharmaceutical care service targeted at optimizing patient drug use, safety and improving treatment outcomes. This study assessed the content and quality of PMC from t...

    Authors: Segun Johnson Showande and Monioluwa Wonuola Laniyan
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:103
  26. The COVID-19 pandemic has harshly burdened the healthcare systems. Health care workers (HCWs) are at substantial risk of infection and confronted several stressors as well leading them to experience burnout. T...

    Authors: Dalal Youssef, Edmond Abboud, Linda Abou-Abbas, Hamad Hassan and Janet Youssef
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:102
  27. General practices in primary care across England are increasingly employing clinical pharmacists to help tackle the workforce crisis and alleviate pressure. Clinical pharmacists can provide administrative and ...

    Authors: Elisha Chopra, Tanvi Choudhary, Ankie Hazen, Sunil Shrestha, Inderpal Dehele and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:101
  28. Pharmacist-led medication reviews are considered a valuable measure to address risks of polypharmacy. The software Medinspector® is used in community pharmacies to assist the performance of this complex service b...

    Authors: Stefan Maierhöfer, Isabell Waltering, Mareike Jacobs, Gudrun Würthwein, Meike Appelrath, Susanne Koling and Georg Hempel
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:100
  29. There is limited data to describe the point-prevalence of healthcare-associated infections (HAIs) among patients at a regional level in Africa. This study estimated the pooled prevalence of HAIs and described ...

    Authors: Usman Abubakar, Omalhassan Amir and Jesús Rodríguez-Baño
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:99
  30. Atrial fibrillation (AF) affects up to 2% of the UK population. AF is a potentially long-term condition that needs management, and as such primary care pharmacists may have a substantial role in supporting the...

    Authors: Shahd Al-Arkee, Julie Mason, Antje Lindenmeyer and Zahraa Jalal
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:98
  31. Globally, cardiovascular disease (CVD) is a leading cause of death and disproportionately affects low- and middle-income countries (LMICs). The WHO Model List of Essential Medicines (WHO EML) is a tool for imp...

    Authors: Ian Naicker, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:97
  32. Appropriate distribution of health care resources is required to adjust regional disparities in the quality of health care. Besides, the number of community pharmacists in Japan has increased recently, but the...

    Authors: Kazuhiro Iguchi, Midori Ueyama, Hiroto Nishio, Hirofumi Tamaki, Arihiro Osanai, Yoko Ino, Kazuya Nonomura, Megumi Horibe, Toshiyuki Matsunaga and Mitsuhiro Nakamura
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:96
  33. Effective vaccine management is essential to maintain the quality of vaccines, minimise wastages, and prevent missed opportunities for vaccination at service delivery points.

    Authors: Bonaventura Nestory, Mackfallen Anasel, Jean Baptiste Nyandwi and Domina Asingizwe
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:95
  34. Globally accepted roles of pharmacists are described in the Good Pharmacy Practice (GPP) standards, published by the World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) in 201...

    Authors: Zuzana Kusynová, Hendrika A. van den Ham, Hubert G. M. Leufkens and Aukje K. Mantel-Teeuwisse
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:94
  35. Lebanon has been recognized as a center for high-quality healthcare services in the Middle East because of its prestigious facilities certified by international bodies, competent health workers, and credible p...

    Authors: Elsa Nassar, Sibelle Kassouf, Aline Hajj, Hala Sacre, Marwan Akel, Rony M. Zeenny, Chadia Haddad and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:93
  36. Despite its importance in ensuring sustainable healthcare, there are huge challenges with pharmaceutical research and development (R&D) especially for developing countries mainly due to the high investment cos...

    Authors: Muluken Nigatu Selam, Samuel Abera, Helen Geremew and Eskinder Eshetu Ali
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:92
  37. Family planning involves the use of traditional or modern methods to prevent maternal and infant mortality associated with unintended pregnancies and negative economic outcomes. In sub-Saharan Africa, the unme...

    Authors: Fredrick Githinji, Shital M. Maru, Peter N. Karimi, Eugene Rutungwa and Egide Kayitare
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:91
  38. Access to quality medicines is a global initiative to ensure universal health coverage. However, the limited capacity of National Medicines Regulatory Authorities (NMRAs) to prevent and detect the supply of po...

    Authors: Jean Baptiste B. Shabani, Egide Kayitare, Eric Nyirimigabo, Vedaste Habyalimana, Marilyn M. Murindahabi, Lazare Ntirenganya, Clarisse Irasabwa, Eugene Rutungwa, Jose Edouard Munyangaju and Innocent Hahirwa
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:90
  39. Yemen's health system has severely deteriorated due to the ongoing civil war accompanied by the COVID-19 pandemic which coincided with other outbreaks of endemic infections. Many health institutions closed due...

    Authors: Ebtesam A. Saleh, Randa N. Haddadin, Bassam Saleh and Eman Elayeh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:89
  40. High-risk medications use at home entails an increased risk of significant harm to the patient. While interventions and strategies to improve medications care have been implemented in hospitals, it remains unc...

    Authors: Irina Dumitrescu, Minne Casteels, Kristel De Vliegher, Laura Mortelmans and Tinne Dilles
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:88
  41. Currently in Greece, no formal organisation offers post-academic education to pharmacists. To improve the clinical practice of pharmacists, there is a need for training that will educate them on how to approac...

    Authors: Aliki Peletidi and Reem Kayyali
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:87
  42. Regular measurement of the availability and use of key medicines for non-communicable diseases allows the tracking of progress to achieve equitable access to medicines. Using a country-level public sector moni...

    Authors: Janeth Tenorio-Mucha, María Lazo-Porras, Jessica Zafra, Margaret Ewen and David Beran
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:86
  43. Efforts in the pharmaceutical market have been aimed at ensuring that the benefits obtained from the introduction of new therapies justify the associated costs. In recent years, drug payment models in healthca...

    Authors: Jose Luis Poveda, Rosa Bretón-Romero, Carlos Del Rio-Bermudez, Miren Taberna and Ignacio H. Medrano
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:85
  44. An irrational antibiotic use is a common problem in developing countries like Ethiopia, which makes empiric antibiotics use difficult. It is considered to be the greatest health problem in our time and future ...

    Authors: Mesay Dechasa, Legese Chelkeba, Amente Jorise, Birbirsa Sefera and Tsegaye Melaku
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:84
  45. Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical...

    Authors: Marwan Akel, Aline Hajj, Hala Sacre, Rony M. Zeenny, Chadia Haddad and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:83
  46. Antimicrobial resistance (AMR) is a global public health issue. Physicians should play a key role to fight AMR, and medical education is a fundamental issue to combat it. Understanding the knowledge, attitudes...

    Authors: Ramin Sami, Raheleh Sadegh, Fataneh Fani, Vajihe Atashi and Hamid Solgi
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:82
  47. Vaccination is an effective public health intervention in reducing morbidity and mortality of infectious diseases. Compared to other countries where community pharmacists (CPs) administer vaccines, CPs in Mala...

    Authors: Wei Chern Ang, Mohamad Syafuan Fadzil, Fatin Najihah Ishak, Nassrah Norissya Adenan and Mohamad Haniki Nik Mohamed
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:81
  48. Allergic rhinitis has been identified as a major respiratory disease that places a significant burden on patients and the healthcare system. Nevertheless, the management of allergic rhinitis is challenging for...

    Authors: Chii-Chii Chew, Chee-Tao Chang, Xin-Jie Lim, Wai-Yin Yong, Doris George, Pathma Letchumanan, Philip Rajan and Chee Ping Chong
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:80
  49. The generalized use of antibiotics has led to the emergence of bacteria which are resistant to antimicrobial agents. This stems in part from the patient's tendencies to seek antibiotics for diseases when not n...

    Authors: Atsushi Ito, Yuichi Watanabe and Takashi Okumura
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:79

Annual Journal Metrics